Alex Pace ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Abstracts this author is presenting:

• A CRISPR-KO whole genome screen identifies factors and pathways that influence the tumour suppressive activity of androgen receptor agonist DHT in estrogen receptor positive breast cancer — ESA Basic Science and Clinical Orals: Innovative Approaches in Endocrine Cancer Diagnosis and Treatment